LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 42 filers reported holding LUMOS PHARMA INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $500,000 | – | 50,000 | – | 0.66% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lion Point Capital, LP | 407,192 | $5,627,000 | 1.23% |
Opaleye Management Inc. | 240,892 | $3,329,000 | 0.65% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 936,291 | $12,940,000 | 0.32% |
NEA Management Company, LLC | 526,663 | $7,278,000 | 0.31% |
Investors Financial Group, LLC | 21,766 | $301,000 | 0.22% |
Wealth Advisors of Iowa, LLC | 11,760 | $163,000 | 0.11% |
Blackstone Inc. | 468,145 | $6,470,000 | 0.02% |
Jefferies Group LLC | 120,651 | $1,667,000 | 0.02% |
Texas Yale Capital Corp. | 16,000 | $221,000 | 0.02% |
Prospera Financial Services Inc | 1,088 | $15,000 | 0.01% |